Search results
Moderna just got FDA approval for its RSV vaccine — only its second product on the market
Quartz· 4 days agoThe Food and Drug Administration on Friday approved Moderna’s mRNA-based respiratory syncytial virus...
Moderna’s stock climbs on report that bird-flu vaccine funding is near
Market Watch· 5 days agoModerna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a...
Moderna's mRNA bird flu vaccine trial is close to getting U.S. government funding
Quartz· 5 days agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1...
Moderna's Options Frenzy: What You Need to Know - Moderna (NASDAQ:MRNA)
Benzinga· 6 days agoVolume & Open Interest Development Looking at the volume and open interest is an insightful way to conduct due diligence on a stock. This data can help you track the liquidity ...
The U.S. Government Is Close To Bankrolling Moderna's Bird Flu Jab
Investor's Business Daily· 5 days agoThe Centers for Disease Control and Prevention classifies the public health risk as low. A Moderna...
3 Sorry Pharma Stocks to Sell in May While You Still Can
InvestorPlace via Yahoo Finance· 6 days agoThere are some pharma stocks to sell in May this year. These companies have been grappling with...
Salesforce, Kohl's and Agilent fall premarket; Foot Locker, Moderna rise By Investing.com
Investing.com· 5 days agoSalesforce, Kohl's and Agilent fall premarket; Foot Locker, Moderna rise
Cathie Wood's ARK buys AMD, sells Moderna in latest stock trades By Investing.com
Investing.com· 7 days agoCathie Wood's ARK buys AMD, sells Moderna in latest stock trades
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Reuters· 5 days ago, opens new tab mRNA bird flu vaccine, the Financial Times reported on Thursday, as the outbreak...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 2 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.